# Olympus closes acquisition of Taewoong Medical for $370M

Olympus Corporation closed the acquisition of Taewoong Medical Co., Ltd., a Korean manufacturer of gastrointestinal metallic stents, for approximately $370 million in cash, with $255.5 million paid upfront and up to $114.5 million in milestone payments.

- Type: Acquisition
- Announced: 2024-01-24
- Where: South Korea
- Value: $370.0M
- Status: completed
- Products: gastrointestinal metallic stents
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Olympus](https://endata.com/companies/30528.md) (acquirer)
- [Taewoong Medical Co., Ltd.](https://endata.com/companies/68772.md) (target)

## Sources

- [olympus-global.com](https://www.olympus-global.com/news/2024/nr02610.html), 2024-01-24: "Olympus Corporation today announced the closing of the acquisition of Taewoong Medical Co., Ltd, a Korea-based manufacturer of medical devices such as gastrointestinal (GI) metallic stents."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.